26/08/2026
**Medical niche. New product. US market. Heavy policy restrictions and a complex sales process involving medical testing**
Still:
✅ 244% more purchases
✅ 69% lower CPA
When we started:
🔴 226 monthly purchases
🔴 $525.94 CPA
A few months later:
✅ 778 monthly purchases
✅ $162.68 CPA
And this wasn’t one lucky spike.
In the first full month, purchases increased by 89.4% while CPA dropped by 66.6%.
From June to July, purchases increased by another 22.5% and CPA dropped by another 30.3%.
And it keeps climbing.
So, how did we do it?
First, the client is a dream to work with:
• Clear ROAS targets based on backend data and an agreed attribution model
• Clear guidelines that allow us to quickly produce videos and banners without unnecessary approval cycles
• Complete freedom to test whatever we believe can work. As long as we meet the targets and follow policy
Most importantly, they continuously improve their internal sales process. When both sides take full responsibility for their part, things can move very quickly.
On our side, we diversified from day one.
We launched campaigns across Google, Meta, X and Bing, while testing other platforms along the way. Even when performance is strong, we keep testing. We never want growth to depend on one account or platform.
And because SEO is also a core part of what we do, we built organic assets around long-tail searches from the beginning. They started ranking and generating traffic quickly.
We also built our own tracking system - the screenshots in this post are taken directly from it.
It connects backend sales and revenue with the advertising platforms, lets us add projected revenue based on estimated LTV and other business data, test different attribution models and see what is actually driving results, not just what the platforms claim.
We may release it as a product soon.
But that’s a post for another day.